The landscape of type 2 diabetes (T2D) management is rapidly evolving, shifting from traditional pharmacotherapy toward advanced device technology. “The challenge, though, is that type 2 diabetes is a progressive…
The most consistent benefits for adults with type 1 diabetes (T1D) can be seen with a combination of a low-carbohydrate diet, education, carbohydrate counting, and modern diabetes technology, such as…
Finerenone (Kerendia) significantly reduced urine albumin-to-creatinine ratio (UACR) by 25% from baseline to 6 months compared with the placebo for patients with type 1 diabetes (T1D) and chronic kidney disease…
Microvascular complications caused by type 2 diabetes (T2D) contribute to cognitive impairment and depression, according to the results of studies published in Diabetes and Metabolic Syndrome. Investigators found that nephropathy…